Morrow Sodali advisor on the Pfizer - Anacor Pharmaceuticals acquisition
27 May 2016 Articles
Morrow Sodali will act as Information Agent in the Pfizer - Anacor Pharmaceutical M&A deal.
Pfizer will acquire Anacor Pharmaceuticals for $5.2 billion, the companies announced Monday.
Related News
The Growing Backlash to DEI and ESG in the U.S. Is Affecting Canadian Companies as Well
12 December 2024
Sodali & Co Celebrates Recognition in FinanceAsia Achievement Awards 2024
09 December 2024
Board assessments: why to do them and the key issues
30 November 2024
Embodied carbon in focus: Navigating investor and industry expectations
13 November 2024
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right